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Phorbol 12-myristate 13-acetate (PMA) induces the differentiation of the human promyelocytic cell line, HL60, towards 
adherent macrophage-like cells within 2 days. We have examined the early effects of PMA on inositol phosphates and 
on diacylglycerol production. two second messengers derived from inositol lipids. In proliferating HL60 cells, PMA in- 
duced a time- and concentration-dependent decrease in inositol phosphate levels. Maximal effects were seen after 1 h 
at IO nM PMA. PMA also induced the translocation of protein kinase C from the cytosol to the membrane. Comparison 
between the differentiating effects of several phorbol esters and of 1-oleoyl-2-acetylglycerol with their ability to inhibit 
inositol phosphate formation suggests that the two effects are correlated. 
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1. INTRODUCTION 
It is now well established that polyphospho- 
inositide phosphodiesterase (PPI-pde) activation is 
one route for generating intracellular signals. A 
wide range of receptor-directed agonists are cou- 
pled to this signalling system and this includes 
some growth factors and mitogens [l]. The pro- 
ducts of PPI-pde activation are IP3 and DG and 
both have second messenger functions. IP3 
mobilises intracellular Ca’+ and DG activates a 
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calcium- and phospholipid-dependent protein 
kinase (protein kinase C). Both of these second 
messengers are involved in the regulation of 
numerous functional responses of the cell in- 
cluding cell proliferation. 
The tumour promoter, PMA, induces the dif- 
ferentiation of HL60 cells, a human promyelocytic 
cell line, towards an adherent macrophage-like cell 
[2,3]. Evidence of macrophage differentiation is 
detectable within 24 h and the process is completed 
within 48 h. Differentiation is accompanied by ar- 
rest of proliferation [2,4]. PMA is also known to 
activate directly protein kinase C and to trans- 
locate the enzyme from the cytosol to the plasma 
membrane [5,6]. The respective roles of protein 
kinase C activation and of the translocation of this 
enzyme into plasma membranes in the process of 
differentiation are not yet clear. Indeed, molecules 
which activate protein kinase C such as OAG or 
byrostatin do not induce differentiation of HL60 
cells [6-81. 
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Here, we investigate the role of PMA on inositol 
phosphate production in HL60 cells during the 
initial stages of differentiation. If the levels of IP3 
and DG are responsible for proliferation, we 
would predict that PMA may cause cessation of 
proliferation by inhibiting the formation of the 
second messengers, IP3 and DG. We demonstrate 
that PMA does decrease the level of inositol phos- 
phates and DG during the reversible step which 
precedes cell commitment towards a macrophage- 
like cell. 
2. MATERIALS AND METHODS 
2.1. Malerials 
Human transferrin, bovine insulin, PMA, PDBu, PRA, 
4cuPDD and OAG were purchased from Sigma. The purchase 
of all other materials has been described [9]. 
2.2. Methods 
Culturing and labelling of HL60 cells with [‘H]inositol have 
been described previously [9]. After labelling, cells were washed 
2-3 times in RPM1 and then resuspended at 25 x IO6 cells/ml 
in RPM1 containing 15% fetal bovine serum (FBS) and LiCl 
(10 mM). PMA (or other related agents) was then added to the 
cells for the indicated times as detailed in the figure legends. 
Aliquots of cells (typically 200 J) were taken from control or 
PMA-treated cells at the indicated times and the reaction 
quenched with chloroform/methanol (1 : 2, v/v). Analysis of in- 
ositol phosphates was carried out as in [IO]. In brief, the 
aqueous phase obtained after extraction of the lipids was loaded 
onto Dowex columns. Total inositol phosphates (IPs) were 
eluted with 1 M ammonium formate in 0.1 M formic acid. 
When the inositol lipids were also analysed, extraction of lipids 
was carried out with acidified chloroform/methanol and the 
lipids separated by TLC as in [ll]. Lipids were localised by 
autoradiography. After evaporation of the solvent, the plates 
were sprayed with EN3HANCE and exposed to Kodak X-Omat 
film for 24 h at -7O’C. The individual spots containing the 
lipids of interest were scraped off and transferred into scintilla- 
tion vials. Methanol (250 $1) was added to elute the lipids before 
addition of scintillant. 
To measure DG, cells were labelled for 48 h in RPM1 sup- 
plemented with FBS by adding 2 &i/ml of [‘HIglycerol to the 
culture medium. After labelling, the cells were washed and 
resuspended at 25 x IO6 cells/ml in fresh culture medium. After 
treatment with PMA, the reaction was quenched with chloro- 
form/methanol (1 :2, v/v). After lipid extraction, DC was 
separated by TLC as in [12] and visualised by autoradiography 
as described above. 
Protein kinase C activity was measured in membrane and 
cytosol fractions prepared from control HL60 cells and cells 
pretreated with PMA. After incubation of the cells with PMA 
(10 nM) for 1 h, the cells were washed, sonicated and the mem- 
branes separated from the cytosol by ultracentrifugation as 
described [13]. Protein kinase C activity was measured in both 
fractions as in [14]. 
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3. RESULTS 
The levels of inositol-containing phospholipids 
and of inositol phosphates in HL60 cells were 
measured after labelling the cells for 48 h. On the 
assumption that the cells had reached isotopic 
equilibrium, the distribution of radioactivity in the 
individual inositol-containing compounds would 
give a measure of the relative amounts present. 
The distribution of [3H]inositol radioactivity 
among the inositol lipids and inositol phosphates 
was phosphatidylinositol (84%), phosphatidyl- 
inositol phosphate (5%), phosphatidylinositol bis- 
phosphate (2.5%), IPi (inositol monophosphate) 
(6.4%), IP2 (inositol bisphosphate) (1.8%) and IP3 
(0.3%). This shows that phosphatidylinositol is the 
major inositol-containing compound and the 
inositol phosphates represent less than 10% of the 
total inositol-containing components. 
IPi can be derived either directly from PI or 
from sequential hydrolysis of IP3 via IP2. In intact 
cells, degradation of IP3 back to inositol is rapid 
and this cycle can be interrupted by adding Li+ 
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Fig. 1. Level of inositol phosphates in HL60 cells after incuba- 
tion with PMA for different times. [‘H]lnositol-labelled cells 
were incubated with 10 nM PMA and at the indicated times, ali- 
quots were removed for the determination of inositol phos- 
phates. Results are expressed as the percentage of inositol 
phosphates in control cells incubated under the same condi- 
tions. Results are means f SD of 5 independent experiments 
done in triplicate. Inset represents the time period between 0 
and 5 min. 
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which blocks the conversion of IPI back to ino- 
sitol. Therefore, all experiments were performed 
by measuring the total inositol phosphates (IPs) 
without further separation. 
Fig. 1 shows the time course of generation of IPs 
after the addition of PMA (10 nM), the concentra- 
tion which has been shown to induce differentia- 
tion of about 90% of cells in 2 days. No significant 
change in levels of IPs was observed for at least 
5 min (see inset to fig. 1). After 10 min, the level of 
IPs begins to decline, reaching about 55% of the 
control level after 1 h and then plateaus. Since the 
ratios of the individual inositol lipids or their 
respective amounts were not changed after 1 h 
treatment with PMA (not shown), the effect of 
PMA is likely to be exerted at the level of forma- 
tion of IPs. Fig.2 illustrates the concentration 
dependence of PMA (measured after 1 h incuba- 
tion). A significant decrease in generation of IPs is 
observed with 3 nM and is maximal by 10 nM. 
It would be expected that a decline in IPs would 
be accompanied by a decrease in DG levels. There- 
fore, we measured the DG levels in cells pretreated 
with PMA (10 nM). As reported in fig.3, the DC 
levels declined to 40 f 3% of the control level after 
1 h and remained at that level for another hour. 
We also studied the effect of molecules related 
to PMA on production of IPs after 1 h incubation 
PMA (log M) 
Concentration PMA PRA PDBu 4cuPDD OAG 
10-s M 55+5 102+13 83k4 113klO nd 
lo-’ M 55 + 6 78 k 9 74 +6 105 + 6 nd 
10m6 M nd 74510 62tl 115+ 5 nd 
50 pg/ml nd nd nd nd 101 * 3 
100 pg/ml nd nd nd nd 108 f 3 
Fig.2. Level of inositol phosphates in HL60 cells after incuba- HL60 cells, prelabelled with [‘Hlinositol, were washed and in- 
tion with different concentrations of PMA. [3H]Inositol- cubated for 1 h at 37°C in the presence of the indicated concen- 
labelled cells were incubated for 1 h with different concentra- trations of the different molecules. The level of inositol 
tions of PMA followed by the determination of inositol phos- phosphates was determined as described in section 2. Results 
phate levels. Results are expressed as the percentage of inositol are expressed as percentage of IPs generated in control cells in- 
phosphates in control cells incubated under the same condi- cubated under the same conditions. Results are means k SD of 
tions. Results are means k SD of 3 independent experiments 3 independent experiments all done in triplicate. nd, not deter- 
done in triplicate. mined 
1 
A 0 
Fig.3. Level of diacylglycerol in control and PMA-treated 
HL60 cells. [‘HIGlycerol-labelled cells were incubated for 1 and 
2 h without or with PMA (10 nM) and the radioactivity in DG 
was measured. A, control cells (100%) after 1 and 2 h incuba- 
tion (1377 + 88 cpm); B,C, percentage of control levels after in- 
cubation with PMA (10 nM) for 1 and 2 h, respectively. Results 
are means + SD of 2 similar experiments done in triplicate. 
(table 1). It is clear that molecules such as PDBu, 
which acts in the same way as PMA, produce the 
same degree of inhibition of production of IPs 
even if higher concentrations are necessary to 
achieve the same decrease. PRA also decreases 
production of IPs but is less potent than PMA, 
whereas 4cuPDD and OAG have no effect on their 
production. 
As it is known that PMA not only activates pro- 
tein kinase C but also translocates it from the 
cytosol to the plasma membranes, we investigated 
Table 1 
Effect of phorbol esters and OAG on inositol phosphate 
production 
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Table 2 
Distribution of protein kinase C activity in control and PMA- 
treated HL60 cells 
Protein kinase C activity 
(pmol histone phosphorylated/mg pro- 
tein per min) 
Cytosol Membrane 
Control cells 430 158 
PMA-treated cells 105 579 
HL60 cells were treated with 10 nM PMA for 1 h at 37°C and 
then washed and disrupted by sonication. The particulate frac- 
tion was separated from the cytosol and protein kinase C activi- 
ty was then determined in both fractions 
whether translocation was effective after 1 h with 
10 nM PMA (table 2). It is clear that the bulk of 
the activity of protein kinase C is located in the 
cytosol in untreated cells whereas most of the 
measured protein kinase C activity is recovered in 
membranes after the cells have been incubated for 
1 h with 10 nM PMA. Moreover, after 1 h incuba- 
tion in the presence of PMA, no loss of protein 
kinase C activity can be observed. 
4. DISCUSSION 
In this study, we demonstrate that PMA, which 
induces differentiation of HL60 cells towards 
macrophage-like cells within 48 h, leads to a 
decrease in IPs and DG after 1 h. The concentra- 
tions required for the induction of differentiation 
and the decline in IPs are similar, suggesting that 
the inhibition of PPI-pde activity is likely to play 
a role in the onset of differentiation itself. The 
ability of the different phorbol esters to induce dif- 
ferentiation is comparable to their ability to inhibit 
the level of IPs. For example, PRA and PDBu, 
which induce differentiation at higher concentra- 
tions and to a lesser extent than PMA [2,4,15], 
cause a smaller decrease in generation of IPs with 
higher drug concentrations than PMA does. In 
contrast, OAG and &PDD, which cannot induce 
differentiation [2,4,8], are also unable to cause a 
decrease in IPs. 
Phorbol esters exert their biochemical effect by 
activating protein kinase C leading to translocation 
of the enzyme to the membranes (table 2) but 
whether this accounts for the differentiating effect 
in HL60 cells is not clear. For example, both OAG 
242 
and bryostatin can activate protein kinase C with- 
out causing differentiation of HL60 cells [6,8,16]. 
It is possible that directional translocation of pro- 
tein kinase C towards plasma membranes and 
long-lasting increased membrane-bound protein 
kinase C activity might be the determining factors 
of whether an activator of protein kinase C can 
lead to differentiation. The importance of direc- 
tional protein kinase C translocation and of its 
association to plasma membranes has been under- 
lined in two studies. The first was performed on 
PMA-differentiation-resistant HL60 subclones 
and demonstrated that the translocation of protein 
kinase C to plasma membranes did not occur in the 
subclones when compared to the sensitive wild type 
[ 171. The second study showed that in two cell lines 
which can be differentiated with PMA (HL60 cells 
and K561), protein kinase C was translocated to 
plasma membranes whereas in PMA-insensitive 
cell lines (CHO and E75KS), translocation of pro- 
tein kinase C occurred towards nuclear membranes 
1181. 
Retinoic acid and DMSO induce differentiation 
of HL60 cells towards granulocytes and both in- 
hibit production of IPs before cell commitment 
(unpublished; and [19]). DMSO also induces the 
differentiation of Friend erythroleukemia cells [20] 
and PMA, that of a pre-B lymphocytic cell line 
[21], and in both cases, each agent provokes inhibi- 
tion of inositol lipid metabolism very early in the 
differentiation process. Differentiation induced by 
all of these agents is preceded by a loss of self- 
renewal potential. Therefore, the observed inhibi- 
tion in inositol lipid metabolism might well be a 
common signal for arrest of proliferation and/or 
initiation of differentiation. 
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